About Us
At Bradford Hill, we have been leading clinical cancer research in Chile for more than 15 years, with a strong focus on immunotherapy. We actively contribute to the global search for new therapies and a definitive cure for this disease, which is today the leading cause of death in the country. We have centers in Santiago and Antofagasta, both with first-class infrastructure and advanced technology, where we run clinical trials following the highest international standards, always prioritizing the safety and well-being of our patients.
Sir Austin Bradford Hill was a pioneer in clinical and epidemiological research. He was recognized for his fundamental work in identifying the causes of lung cancer and his contribution to developing statistical methods in medical research. The Bradford Hill Criteria remain a key reference for establishing causal relationships in clinical studies. At the same time, his meticulous approach and innovative vision continue to inspire those of us who seek to advance clinical research and improve medical treatments, especially in the fight against cancer.
